Immediate Impact

2 by Nobel laureates 24 from Science/Nature 64 standout
Sub-graph 1 of 22

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Naturally occurring T cell mutations enhance engineered T cell therapies
2024 StandoutNature
3 intermediate papers

Works of Sally L. Glaser being referenced

Impaired Immune Health in Survivors of Diffuse Large B-Cell Lymphoma
2020
Epstein-Barr Virus As a Marker of Survival After Hodgkin's Lymphoma: A Population-Based Study
2005

Author Peers

Author Last Decade Papers Cites
Sally L. Glaser 3801 1932 922 115 5.9k
Franck Chauvin 3258 2838 492 163 6.6k
Roberta De Angelis 3176 1024 902 98 5.8k
Sara S. Strom 1532 1086 939 140 6.3k
Maria J. Schymura 3225 950 1015 122 6.6k
Timothy S. McNeel 2822 765 1108 97 5.3k
Joyce C. Niland 3376 1644 950 158 8.2k
Lindsay M. Morton 3821 4335 1036 201 9.2k
Rosemary D. Cress 3846 752 1007 126 6.7k
Marc Maynadié 1655 1795 1077 129 5.3k
Fabio Falcini 2350 1212 817 260 5.3k

All Works

Loading papers...

Rankless by CCL
2026